The Diversion of Ultram,® Ultracet,® and Generic Tramadol HCL

Author： Inciardi James A.   Cicero Theodore J.   Munoz Alvaro   Adams Edgar H.   Geller Anne   Senay Edward C.   Woody George E.  

Publisher： Haworth Press

ISSN： 1055-0887

Source： Journal of Addictive Diseases, Vol.25, Iss.2, 2006-06, pp. : 53-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Design and development of nasal mucoadhesive microspheres containing tramadol HCl for CNS targeting

By Belgamwar Veena S.   Patel Hitesh S.   Joshi Ashwini S.   Agrawal Anshuman   Surana Sanjay J.   Tekade Avinash R.  

Drug Delivery, Vol. 18, Iss. 5, 2011-07 ,pp. : 353-360

Informa Healthcare

Access to resources Recommend Favorite

Drug Identification Calls From Law Enforcement Received by Texas Poison Control Centers, 2002â–“2004

By Forrester Mathias B.  

Journal of Toxicology and Environmental Health, Vol. 69, Iss. 22, 2006-06 ,pp. : 2041-2049

Taylor & Francis Ltd

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Amifostine (Ethyol®) in Patients with Non-Small Cell Lung Cancer

By Touchette Daniel R.   Stevenson J. G.   Jensen Gail  

Journal of Aging & Pharmacotherapy, Vol. 13, Iss. 2, 2007-02 ,pp. : 109-126

Haworth Press

Access to resources Recommend Favorite

Tramadol/Paracetamol

By McClellan K.   Scott L.J.  

Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. : 1079-1086

Adis International

Access to resources Recommend Favorite

Clinical Pharmacology of Tramadol

By Stefan Grond   Armin Sablotzki  

Clinical Pharmacokinetics, Vol. 43, Iss. 13, 2004-01 ,pp. : 879-923

Adis International

Access to resources Recommend Favorite